Journal of the American Chemical Society
Communication
Fluorine Compounds; Roesky, H. W., Ed.; Wiley: Hoboken, NJ, 2013; p
205 and references cited therein. (e) Nagaki, A.; Tokuoka, S.; Yamada,
S.; Tomida, Y.; Oshiro, K.; Amii, H.; Yoshida, J.-i. Org. Biomol. Chem.
2011, 9, 7559.
(6) (a) Krishnamurti, R.; Bellew, D. R.; Prakash, G. K. S. J. Org. Chem.
1991, 56, 984. (b) Dilman, A. D.; Arkhipov, D. E.; Levin, V. V.;
Belyakov, P. A.; Korlyukov, A. A.; Struchkova, M. I.; Tartakovsky, V. A. J.
Org. Chem. 2008, 73, 5643. (c) Prakash, G. K. S.; Wang, Y.; Mogi, R.; Hu,
J.; Mathew, T.; Olah, G. A. Org. Lett. 2010, 12, 2932.
ASSOCIATED CONTENT
* Supporting Information
Full details of synthetic (PDF) and crystallographic (CIF)
studies. This material is available free of charge via the Internet at
■
S
AUTHOR INFORMATION
Corresponding Author
■
(7) (a) Barhdadi, R.; Troupel, M.; Perichon, J. Chem. Commun. 1998,
1251. (b) Russell, J.; Roques, N. Tetrahedron 1998, 54, 13771.
(8) (a) Petrov, V. A. Tetrahedron Lett. 2001, 42, 3267. (b) Pooput, C.;
Notes
́
Dolbier, W. R., Jr.; Medebielle, M. J. Org. Chem. 2006, 71, 3564.
(9) Filler, R. Adv. Fluorine Chem. 1970, 6, 1.
The authors declare no competing financial interest.
(10) (a) Davidson, R. I. U.S. Patent 4,822,904, 1989. (b) Carr, G. E.;
Chambers, R. D.; Holmes, T. F.; Parker, D. G. J. Chem. Soc., Perkin Trans.
1 1988, 921. (c) Freskos, J. N. Synth. Commun. 1988, 18, 965.
(d) Langlois, B. R.; Roques, N. J. Fluorine Chem. 2007, 128, 1318.
(11) Urata, H.; Fuchikami, T. Tetrahedron Lett. 1991, 32, 91.
(12) (a) Burton, D. J.; Wiemers, D. M.; Easdon, J. C. U.S. Patent
4,582,921, 1986. (b) Kremlev, M. M.; Tyrra, W.; Mushta, A. I.;
Naumann, D.; Yagupolskii, Y. L. J. Fluorine Chem. 2010, 131, 212.
(c) Kobayashi, Y.; Kumadaki, I. J. Chem. Soc., Perkin Trans. 1 1980, 661.
(13) One ArI substrate has been pentafluoroethylated with
[(DMPU)2Zn(C2F5)2] in the presence of CuCl (10%) and phen
(20%). See: Popov, I.; Lindeman, S.; Daugulis, O. J. Am. Chem. Soc.
2011, 133, 9286.
(14) (a) A few examples of pentafluoroethylation of activated
bromoarenes have been reported.10b,c,12b Attempted Cu-catalyzed
perfluoroalkylation of 4-bromobiphenyl with [(DMPU)2Zn(Rf)2]
generated in situ from RfH gave the desired product in <5% yield.13
(b) Pd-catalyzed borylation of a few unactivated aryl bromides followed
by oxidative fluoroalkylation of the resultant arylboronate esters with
[(phen)CuC2F5] has been reported. See: Litvinas, N. D.; Fier, P. S.;
Hartwig, J. F. Angew. Chem., Int. Ed. 2012, 51, 536.
ACKNOWLEDGMENTS
■
We thank Drs. Jordi Benet-Buchholz and Eddy Martin for single-
crystal X-ray diffraction studies and Dr. Alessandro Zanardi and
Maxim A. Novikov for selected preliminary experiments. The
ICIQ Foundation and the Spanish Government (Grant
CTQ2011-25418) are thankfully acknowledged for support of
this work.
REFERENCES
■
(1) For selected recent monographs, see: (a) Kirsch, P. Modern
Fluoroorganic Chemistry; Wiley-VCH: Weinheim, Germany, 2004.
(b) Uneyama, K. Organofluorine Chemistry; Blackwell: Oxford, U.K.,
2006. (c) Ojima, I. Fluorine in Medicinal Chemistry and Chemical Biology;
Wiley-Blackwell: Chichester, U.K., 2009. (d) Petrov, V. A. Fluorinated
Heterocyclic Compounds: Synthesis, Chemistry and Applications; Wiley:
Hoboken, NJ, 2009.
(2) For selected reviews, see: (a) Burton, D. J.; Yang, Z.-Y. Tetrahedron
1992, 48, 189. (b) McClinton, M. A.; McClinton, D. A. Tetrahedron
1992, 48, 6555. (c) Dolbier, W. R., Jr. Chem. Rev. 1996, 96, 1557.
(d) Umemoto, T. Chem. Rev. 1996, 96, 1757. (e) Burton, D. J.; Lu, L.
Top. Curr. Chem. 1997, 193, 45. (f) Prakash, G. K. S.; Yudin, A. K. Chem.
Rev. 1997, 97, 757. (g) Singh, R. P.; Shreeve, J. M. Tetrahedron 2000, 56,
7613. (h) Cahard, D.; Ma, J.-A. Chem. Rev. 2004, 104, 6119.
(i) Schlosser, M. Angew. Chem., Int. Ed. 2006, 45, 5432. (j) Cahard,
D.; Ma, J.-A. J. Fluorine Chem. 2007, 128, 975. (k) Uneyama, K.; Katagiri,
T.; Amii, H. Acc. Chem. Res. 2008, 41, 817. (l) Ma, J.-A.; Cahard, D.
Chem. Rev. 2008, 108, PR1. (m) Davis, C. R.; Burton, D. J. In The
Chemistry of Organocopper Compounds; Rappoport, Z., Marek, I., Eds.;
Wiley: Chichester, U.K., 2009. (n) Shibata, N.; Matsnev, A.; Cahard, D.
Beilstein J. Org. Chem. 2010, 6, 65. (o) Sato, K.; Tarui, A.; Omote, M.;
Ando, A.; Kumadaki, I. Synthesis 2010, 1865. (p) Dhara, M. G.; Banerjee,
S. Prog. Polym. Sci. 2010, 35, 1022. (q) Roy, S.; Gregg, B. T.; Gribble, G.
W.; Le, V.-D.; Roy, S. Tetrahedron 2011, 67, 2161. (r) Tomashenko, O.
A.; Grushin, V. V. Chem. Rev. 2011, 111, 4475. (s) Qing, F.-L.; Zheng, F.
Synlett 2011, 1052. (t) Dilman, A. D.; Levin, V. V. Eur. J. Org. Chem.
2011, 831. (u) Nie, J.; Guo, H.-C.; Cahard, D.; Ma, J.-A. Chem. Rev.
2011, 111, 455. (v) Grygorenko, O. O.; Artamonov, O. S.; Komarov, I.
(15) Zanardi, A.; Novikov, M. A.; Martin, E.; Benet-Buchholz, J.;
Grushin, V. V. J. Am. Chem. Soc. 2011, 133, 20901.
(16) Novak
2012, 51, 7767.
(17) Novak, P.; Lishchynskyi, A.; Grushin, V. V. J. Am. Chem. Soc. 2012,
134, 16167.
́
, P.; Lishchynskyi, A.; Grushin, V. V. Angew. Chem., Int. Ed.
́
(18) Reported 19F NMR data for “CuC2F5”: δ −82.8 (3F), −110.0
(2F).12,19 For [Cu(C2F5)2]−: δ −82.9 (3F), −116.1 (2F).14b,20
(19) Wiemers, D. M.; Burton, D. J. J. Am. Chem. Soc. 1986, 108, 832.
(20) Naumann, D.; Roy, T.; Caeners, B.; Hutten, D.; Tebbe, K.-F.;
Gilles, T. Z. Anorg. Allg. Chem. 2000, 626, 999.
(21) In contrast with the cupration of CHF3,15 which cannot be
efficiently carried out in THF, the reaction of preisolated [K(DMF)][(t-
BuO)2Cu] with C2F5H in THF afforded 1, albeit in a slightly lower yield
(81%). No formation of [Cu(C2F5)2]− was detected in this case.
(22) See the Supporting Information for details.
(23) In contrast with fluoroform-derived CuCF3,15 the CuC2F5 reagent
produced upon treatment with HCl or AcOH is stable.
V.; Mykhailiuk, P. K. Tetrahedron 2011, 67, 803. (w) Acena, J. L.;
Sorochinsky, A. E.; Soloshonok, V. A. Synthesis 2012, 44, 1591.
̃
(24) Hughes, R. P.; Meyer, M. A.; Tawa, M. D.; Ward, A. J.;
Williamson, A.; Rheingold, A. L.; Zakharov, L. N. Inorg. Chem. 2004, 43,
747.
(x) Mace,
́
Y.; Magnier, E. Eur. J. Org. Chem. 2012, 2479.
(3) See, for example: (a) Andrzejewska, M.; Yep
́
ez-Mulia, L.; Cedillo-
(25) The formation of [(Et3P)2Pd(C2F5)I] in unspecified yield via
condensation of Pd vapor with Et3P and C2F5I has been mentioned. See:
Klabunde, K. J.; Low, J. Y. F. J. Am. Chem. Soc. 1974, 96, 7674.
(26) Grushin, V. V.; Marshall, W. J. J. Am. Chem. Soc. 2006, 128, 4632.
(27) Although X-ray analysis has been performed for trans-
[(Ph2PMe)2Pt(Rf)Cl] (Rf = CF3, C2F5), packing disorder in the CF3
complex precludes comparison of the structural trans influences of C2F5
and CF3. It has been suggested on the basis of the ν(Pt−Cl) values that
the IR trans influences of CF3 and C2F5 are similar. See: Bennett, M. A.;
Chee, H.-K.; Robertson, G. B. Inorg. Chem. 1979, 18, 1061.
(28) Bent, H. A. Chem. Rev. 1961, 61, 275.
Rivera, R.; Tapia, A.; Vilpo, L.; Vilpo, J.; Kazimierczuk, Z. Eur. J. Med.
Chem. 2002, 37, 973. (b) Johansson, A.; Poliakov, A.; Åkerblom, E.;
Wiklund, K.; Lindeberg, G.; Winiwarter, S.; Danielson, U. H.;
Samuelsson, B.; Hallberg, A. Bioorg. Med. Chem. 2003, 11, 2551.
(4) (a) Gassman, P. G.; O’Reilly, N. J. Tetrahedron Lett. 1985, 26, 5243.
(b) Gassman, P. G.; O’Reilly, N. J. J. Org. Chem. 1987, 52, 2481.
(5) (a) Schneider, M.; Marhold, A.; Kolomeitsev, A.; Kadyrov, A.;
Roschenthaler, G.-V.; Barten, J. U.S. Patent 6,872,861, 2005.
(b) Kolomeitsev, A. A.; Kadyrov, A. A.; Szczepkowska-Sztolcman, J.;
Milewska, M.; Koroniak, H.; Bissky, G.; Barten, J. A.; Roschenthaler, G.-
V. Tetrahedron Lett. 2003, 44, 8273. (c) Shevchenko, N. E.; Nenajdenko,
̈
̈
V. G.; Roschenthaler, G.-V. J. Fluorine Chem. 2008, 129, 390.
̈
(d) Kazakova, O.; Roschenthaler, G.-V. In Efficient Preparations of
̈
D
dx.doi.org/10.1021/ja407017j | J. Am. Chem. Soc. XXXX, XXX, XXX−XXX